Incorporation of the 40-gene expression profile (40-GEP) test to improve treatment decisions in high-risk cutaneous squamous cell carcinoma (cSCC) patients: case …

G Singh, SN Tolkachjov, AS Farberg - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Cutaneous squamous cell carcinoma (cSCC) has become a significant public health issue
due to its rapidly rising incidence and an estimated 1.8 million newly diagnosed cases …

[HTML][HTML] Value-Based Healthcare: A primer for the dermatologist

DMW Balak, E Deprez, NT Hilhorst, I Hoorens… - Dermatology, 2024 - karger.com
Background: Value-based healthcare (VBHC) is an increasingly employed strategy to
transform healthcare organizations into economically sustainable systems that deliver high …

Protocol for development of a core outcome set for clinical trials in melasma

SA Ibrahim, BY Kang, DI Schlessinger, SG Chiren… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Melasma is a pigmentation disorder of the skin. Characterised by brown to gray-
brown patches on the face and neck, the condition predominantly affects women and has …

Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting

MKA Dirr, M Alam, C Apfelbacher, KP Drewitz… - Archives of …, 2023 - Springer
A COS is a systematically developed list of outcomes recommended for reporting all studies
within a particular disease area. The Cochrane Skin–Core Outcome Set Initiative (CS …

Identifying critical quality metrics in Mohs Surgery: A national expert consensus process

JA Dodson, SA Ibrahim, H Rogers, ML Council… - Journal of the American …, 2024 - Elsevier
Background Amid a movement toward value-based healthcare, increasing emphasis has
been placed on outcomes and cost of medical services. To define and demonstrate the …

[HTML][HTML] Identification of potential immune-related circRNA-miRNA-mRNA regulatory network in cutaneous squamous cell carcinoma

Y Wei, X Yang, L Gao, J Yang, L Zheng… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Circulating RNAs (circRNAs) are involved in tumor development and progression by
participating in immune regulation. Nevertheless, the circRNAs expression profiles and their …

Core outcome sets in clinical laser research: how better evidence can be better for patients

BY Kang, SA Ibrahim, E Poon, M Alam - Lasers in Medical Science, 2022 - Springer
Core outcome sets, or the minimum sets of outcomes that would be used in all clinical
studies of a given disease or condition, have the potential to revolutionize clinical research …

Usefulness of core outcome sets in cosmetic dermatology: Better data leads to improved treatments.

SA Ibrahim, BY Kang, E Poon… - Journal of Cosmetic …, 2022 - search.ebscohost.com
In the future, use of core outcome sets in cosmetic treatments may lead to more effective
treatments, and better defined clinical practice guidelines for cosmetic therapies. 5, 6 …

[PDF][PDF] Murad Alam, MD, MSCI, MBA

US Citizenship - 2022 - ilds.org
MURAD ALAM Page 1 Page 1 of 125 Curriculum Vitae Date: July 1, 2022 Murad Alam, MD,
MSCI, MBA PERSONAL INFORMATION Work Address 676 N. St. Clair Street, Ste. 1600 Chicago …

[PDF][PDF] Cutaneous squamous cell carcinoma of the head and neck

A Leus - 2022 - research.rug.nl
Skin cancer is the most common cancer in the fair-skinned population, with a rising
incidence worldwide. 1, 2 There are many different forms of skin cancer, with melanoma …